OurCrowd portfolio company ReWalk, developer of the FDA approved ReWalk exoskeleton device, was featured on Bloomberg Television’s “Bottom Line.” In the interview, ReWalk Robotics CEO Larry Jasinksi speaks with Elliott Gotkine about the prospects for the exoskeleton market and the company’s product development plans.

ReWalk raised $1,320,000 from OurCrowd investors in June 2013.

View the video on Bloomberg TV here.